We read with interest the article by Spadaccini et al 1 evaluating gastric peroral endoscopic pyloromyotomy (G-POEM) for refractory gastroparesis. The authors found that G-POEM for refractory gastroparesis was effective and safe. Because their findings are important to current practice, several questions deserve attention. First, according to the authors' inclusion and exclusion criteria, 2 important articles, which included 73 patients, were not included. 2,3 Because there are relatively few cases of G-POEM for refractory gastroparesis, studies on G-POEM for refractory gastroparesis should be searched as comprehensively as possible. Second, the authors used "significant symptomatic improvement" as an assessment measurement; however, the definition of "significant symptomatic improvement" was quite different across the included studies. In other words, it was a subjective judgment that might have caused significant heterogeneity and may not be an ideal measurement to evaluate the effectiveness of G-POEM. Third, the Gastroparesis Cardinal Symptom Index (GCSI) was also used, but the author overlooked that dynamic change occurred in the GCSI in the follow-up. For instance, the GCSI in the report by Gonzalez et al 4 was 3.3 before the procedure, 0.95 at 1 to 3 months postoperatively, 1.0 at 6 months postoperatively, and 1.1 at 12 months postoperatively. The authors chose only 0.95 to calculate the pooled result, which might not have reflected the true effectiveness of G-POEM. Moreover, the author did not report the heterogeneity of the pooled GCSI. According to our results, the heterogeneity is very significant across the included studies, which means that the GCSI was also not an ideal assessment measurement owing to subjective attribution. In addition, we should pay attention to relapse after G-POEM. Last, all of the included studies were single-arm studies, and no comparison was made, so randomized controlled trials are still needed to compare the G-POEM with other approaches in the future.